Indian drug regulators inspecting J&J's talcum powder amid 'cancer' concerns
The visits come as the regulators in India launch an investigation into the company's Baby Powder following a Reuters report last Friday that the firm knew for decades that cancer-causing asbestos lurked in the product.
"Today, a few of our facilities were visited by the CDSCO and local FDA authorities and we are fully co-operating with them by providing tests and samples," the J&J statement said. "The characterization of these visits as "raids" or "seizures" is incorrect as has been reported in some instances. The tests have been conducted in the regular way that the FDA collects samples."
Johnson & Johnson added that the safety of its cosmetic talc was based on a long history of safe use and decades of research and clinical evidence by independent researchers and scientific review boards across the world.
It also said Indian FDA and the CDSCO have in the past confirmed that its products "comply with Indian standards and are free of asbestos".
(With inputs from agencies.)
- JKLF chairman Yasin Malik detained by police during protests in Srinagar
- REFILE-Tests at Cuadrilla's UK fracking site show substantial gas flows
- TDB pitches for equality in SC after violent Sabarimala protests over entry of women
- Ruckus in Karnataka Assembly after BJP leaders claim 'no govt' in protests
- Delhi govt to reward informers to bring in light sex determination tests